Shanghai Junshi Bios...
SEHK:1877
HK$ 23,16
+ HK$0,08 (0,35%)
23,16 HK$
+HK$0,08 (0,35%)
End-of-day quote: 03/31/2026

Competitors

Companies Market Cap G R O W T H
Innovent Biologics
SEHK:1801
149,40 B 25,34% 4/6 42,75% -41,62% 32,81% UP
Akeso
SEHK:9926
122,60 B 0,00% 3/5 76,14% -164,77% 31,70% UP
RemeGen
SEHK:9995
72,41 B 74,34% 0/0 85,35% -129,20% 6,94% UP
3SBio
SEHK:1530
60,64 B 12,07% 6/6 66,56% -91,59% 55,97% UP
Shanghai RAAS Blood Products
SZSE:002252
38,23 B 17,83% 3/5 32,64% 21,59% -100,00% DOWN
Biocytogen Pharmaceuticals (Beijing)
SEHK:2315
41,53 B 71,02% 0/0 92,28% -143,79% -100,00% UP
Chongqing Zhifei Biological Products
SZSE:300122
36,36 B 9,60% 2/6 -29,06% 49,44% 54,71% DOWN
Changchun High-Tech Industry (Group)
SZSE:000661
34,83 B 23,32% 5/6 12,42% 70,21% 73,81% DOWN
Shanghai Henlius Biotech
SEHK:2696
37,85 B 113,19% 6/6 7,74% 18,86% 42,94% UP
China Biologic Products Holdings
NasdaqGS:CBPO
4,65 B 0,00% 2/4 0,00% 0,00% -100,00% UP
Beijing Tiantan Biological Products
SHSE:600161
30,06 B 6,01% 3/6 29,07% 50,14% 57,89% DOWN
Hualan Biological Engineering
SZSE:002007
26,83 B -5,46% 0/6 48,06% 37,27% 24,66% DOWN
Xiamen Amoytop Biotech
SHSE:688278
26,63 B 0,00% 4/5 31,45% 55,99% -100,00% DOWN
Giant Biogene Holding
SEHK:2367
29,73 B 20,09% 0/0 6,48% 36,48% 50,36% DOWN
Suzhou Zelgen Biopharmaceuticals
SHSE:688266
25,55 B 0,00% 5/6 116,59% -0,01% 50,24% UP
InnoCare Pharma
SEHK:9969
27,74 B 330,49% 2/5 -8,96% 16,03% 45,97% UP
Dizal (Jiangsu) Pharmaceutical
SHSE:688192
25,83 B 0,00% 0/0 107,19% 65,16% 93,36% DOWN
BrightGene Bio-Medical Technology
SHSE:688166
20,97 B 5,03% 4/5 39,07% 11,43% -100,00% DOWN
Walvax Biotechnology
SZSE:300142
20,04 B 11,56% 3/6 97,68% 17,24% -44,13% DOWN
BGI Genomics
SZSE:300676
16,01 B 0,00% 2/3 0,00% 0,00% 0,00% UP
×